期刊
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
卷 17, 期 -, 页码 109-111出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jgar.2018.11.014
关键词
Carbapenemase-producing Klebsiella pneumoniae; KPC; Ceftazidime/avibactam; Ceftazidime; Gut decolonisation
资金
- Italian Society of Infectious and Tropical Diseases (SIMIT)
Objectives: KPC-producing Klebsiella pneumoniae (KPC-Kp) gut colonisation is a major risk factor for developing systemic infection. Ceftazidime/avibactam (CAZ/AVI) may have a role as decolonisation therapy in special situations. Methods: This was a retrospective, observational, multicentre study. The KPC-Kp gut decolonisation rate of CAZ/AVI-based therapy (Group A) was compared with other antimicrobial regimens (Group B) in patients with KPC-Kp infection. Results: Among 12 patients in Group A, 11 (91.7%) achieved gut decolonisation. None of the 24 patients of Group B were decolonised. Conclusion: CAZ/AVI-based therapy could be useful in KPC-Kp gut decolonisation in high-risk patients. (C) 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据